Rapid Test Kit Market Size and Outlook 2031

Report Description

Forecast Period	2027-2031
Market Size (2025)	USD 28.36 Billion
CAGR (2026-2031)	10.05%
Fastest Growing Segment	Rapid Antigen Test
Largest Market	Asia Pacific
Market Size (2031)	USD 50.38 Billion

Market Overview

The Global Rapid Test Kit Market will grow from USD 28.36 Billion in 2025 to USD 50.38 Billion by 2031 at a 10.05% CAGR. The Global Rapid Test Kit Market encompasses the diagnostic sector focused on disposable devices designed to provide qualitative or semi-quantitative results for specific medical conditions within minutes, facilitating immediate clinical decisions without complex laboratory equipment. The market's expansion is fundamentally supported by the rising prevalence of infectious diseases and a paradigm shift toward decentralized healthcare, which drives the demand for accessible point-of-care testing solutions. According to The Global Fund, in 2024, the partnership distributed over 6.4 million individual HIV self-test kits, illustrating the substantial reliance on these diagnostics for disease management and public health monitoring.

However, the market faces a significant impediment regarding stringent regulatory approval processes and quality assurance concerns. Manufacturers must navigate complex compliance landscapes to minimize the risks of false positives or negatives, as inconsistent product accuracy can lead to mandatory recalls and heightened scrutiny from health authorities, thereby delaying commercialization and creating high barriers to entry for emerging competitors.

Key Market Drivers

Escalating prevalence of infectious diseases acts as a primary catalyst for the Global Rapid Test Kit Market, necessitating immediate solutions for outbreak management. The resurgence of vector-borne illnesses has intensified reliance on rapid assays that deliver results at the point of need, effectively bypassing laboratory delays. This burden creates a critical requirement for high-volume screening tools to curb transmission. According to the Pan American Health Organization, October 2024, in the 'Epidemiological Alert - Increase in dengue cases in the Americas Region', countries reported over 11.7 million dengue cases by epidemiological week 36 of 2024, a figure 2.5 times higher than the 2023 total. Such infection rates directly drive the procurement of rapid diagnostics for early intervention.

Simultaneously, the surge in adoption of home-based and over-the-counter (OTC) diagnostic kits is expanding the market, reflecting a shift toward decentralized healthcare. Regulatory bodies are validating self-testing platforms, enabling manufacturers to transition products to standard commercial availability. According to the U.S. Food and Drug Administration, October 2024, in 'FDA Authorizes Marketing of First Home Flu and COVID-19 Combination Test Outside of Emergency Use Authorities', the agency authorized the Healgen Rapid Check COVID-19/Flu A&B Antigen Test, the first OTC combination test approved via the traditional premarket pathway. This segment's resilience is evident; according to Abbott, February 2024, in its '2023 Annual Report', Rapid Diagnostics achieved a 1.3 percent sales increase in 2023 excluding COVID-19 volatility, confirming sustained demand for point-of-care solutions.

Download Free Sample Report

Key Market Challenges

The Global Rapid Test Kit Market faces a substantial hurdle due to stringent regulatory approval processes and persistent quality assurance concerns. Manufacturers are required to navigate highly complex compliance frameworks that demand rigorous clinical validation and extensive documentation to ensure product accuracy. These elevated standards impose significant financial and operational burdens, particularly on smaller enterprises, effectively creating high barriers to entry. The necessity for absolute precision to avoid false results forces companies to invest heavily in quality control, which extends development timelines and delays the introduction of new diagnostic tools to the market.

This regulatory environment directly impedes market expansion by slowing commercialization and discouraging investment in specific regions. According to MedTech Europe, in 2024, the selection of the European Union as the priority region for first product launches declined by 33% among large manufacturers compared to previous regulatory periods, primarily due to the unpredictability and resource intensity of the certification process. Such delays restricts the availability of rapid testing solutions and limit the industry's ability to respond quickly to emerging health needs. Furthermore, the risk of mandatory recalls due to quality inconsistencies creates a volatile environment, forcing manufacturers to allocate resources toward compliance management rather than capacity expansion.

Key Market Trends

The Integration of Artificial Intelligence and Smartphone Connectivity is fundamentally reshaping the Global Rapid Test Kit Market by enhancing diagnostic accuracy and user accessibility. Manufacturers are increasingly embedding AI algorithms into diagnostic platforms to automate result interpretation, thereby reducing the subjectivity and potential human error associated with visual readings of lateral flow assays. This technological convergence enables real-time data digitization and connectivity, allowing for immediate reporting and surveillance of infectious diseases. A prime example of this trend is Predictmedix AI Inc., which reported in April 2025 in a company announcement that its Smart Health AI Stations had completed over 500,000 individual scans, utilizing computer vision and machine learning to detect health indicators and infectious disease signs with high precision, demonstrating the scalability of AI-driven screening solutions.

Simultaneously, the market is witnessing significant Diversification into Veterinary Diagnostics and Food Safety Testing, driven by the need for rapid, point-of-care solutions in animal health and supply chain monitoring. This trend is characterized by the migration of advanced diagnostic technologies from human healthcare to veterinary and industrial applications, facilitating lab-quality results outside of traditional laboratory settings. Illustrating this expansion, Zoetis, in December 2024, announced the global launch of the Vetscan OptiCell, the first cartridge-based, AI-powered hematology analyzer designed for point-of-care veterinary use. This innovative device, which uses proprietary microfluidic technology to provide complete blood count analysis in minutes, underscores the industry's commitment to broadening the application of rapid diagnostic kits to companion animal care.

Segmental Insights

The Rapid Antigen Test segment constitutes the fastest-growing category within the Global Rapid Test Kit Market, driven by the increasing demand for cost-effective and immediate diagnostic results. This growth is supported by the heightened need to manage infectious diseases through accessible screening methods. Regulatory bodies, such as the U.S. Food and Drug Administration, have facilitated this expansion by granting authorizations that accelerate product availability. Consequently, the operational simplicity of these tests enables widespread adoption across point-of-care settings, allowing healthcare providers to deliver timely diagnoses without relying on complex laboratory infrastructure.

Regional Insights

Asia Pacific commands a dominant position in the Global Rapid Test Kit Market, primarily driven by the high prevalence of infectious diseases and a massive patient pool requiring immediate diagnostic solutions. Major economies such as China and India are actively expanding their healthcare infrastructure, which significantly fuels the demand for cost-effective point-of-care testing. Furthermore, supportive initiatives by local governments and regulatory agencies to accelerate product approvals encourage widespread adoption. This focus on decentralized diagnostics, combined with rising healthcare expenditure and a growing geriatric demographic, firmly establishes the region as the global leader in this sector.

Recent Developments

In September 2025, QuidelOrtho Corporation expanded its respiratory diagnostic portfolio by launching the QUICKVUE Influenza + SARS Test for professional use in the United States. This CLIA-waived rapid immunoassay was designed to simultaneously detect and differentiate influenza A, influenza B, and SARS-CoV-2 antigens from a single nasal swab sample. The test provided visual results in approximately 10 minutes, enabling healthcare providers in urgent care and physician office settings to efficiently diagnose coinfections. This launch reinforced the company's commitment to delivering accessible point-of-care solutions that streamline clinical decision-making during respiratory virus seasons.
In July 2025, BD (Becton, Dickinson and Company) secured 510(k) clearance from the U.S. Food and Drug Administration for its BD Veritor System for SARS-CoV-2. This regulatory milestone transitioned the digital rapid antigen test from its previous Emergency Use Authorization status to a fully cleared diagnostic solution. The test utilized a chromatographic digital immunoassay to detect viral antigens in symptomatic individuals within 15 minutes. By achieving this clearance, the company ensured the continued availability and reliability of its point-of-care testing platform for healthcare facilities, retail clinics, and physician offices across the widespread diagnostic market.
In June 2024, Cepheid obtained De Novo marketing authorization and a CLIA waiver from the U.S. Food and Drug Administration for its Xpert HCV test. This molecular diagnostic became the first in the United States authorized to detect Hepatitis C Virus RNA directly from a capillary whole blood fingerstick sample. The test, which runs on the GeneXpert Xpress System, was designed to deliver results in approximately one hour at the point of care. This authorization addressed barriers to diagnosis by simplifying testing algorithms and enabling immediate linkage to care for patients in decentralized healthcare settings.
In June 2024, Roche received Emergency Use Authorization from the U.S. Food and Drug Administration for its cobas liat SARS-CoV-2, Influenza A/B, and RSV nucleic acid test. This automated multiplex real-time PCR assay was developed to detect and differentiate four prevalent respiratory viruses using a single nasopharyngeal or anterior nasal swab sample. The system generated definitive results in just 20 minutes, making it suitable for point-of-care settings such as emergency departments and urgent care clinics. This approval allowed healthcare professionals to quickly rule out or confirm infections during patient visits, facilitating timely treatment decisions.

Key Market Players

Abbott Laboratories
F. Hoffmann-La Roche Ltd.
Siemens Healthineers
Danaher Corporation
Becton, Dickinson and Company (BD)
bioMérieux SA
Thermo Fisher Scientific Inc.
PerkinElmer Inc.
Bio-Rad Laboratories Inc.
ACON Laboratories Inc.

By Type	By Product Type	By Technology	By Duration	By Application	By End User	By Region
Rapid Antigen Test v/s Rapid Antibody Test	Over-the-counter {OTC} Rapid Test Kit v/s Professional Rapid Test Kit	Lateral Flow Assays Solid Phase Agglutination Immunospot Assay	Less than 30 Minutes Less than 10 Minutes Less than 1 Hour 1 Hour - 2 Hour Others	Infectious Disease Glucose Monitoring Pregnancy & Fertility Toxicology Cardiology Oncology Others	Hospitals & Clinics Home Care Diagnostic Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Rapid Test Kit Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Rapid Test Kit Market, By Type:

Rapid Antigen Test v/s Rapid Antibody Test

Rapid Test Kit Market, By Product Type:

Over-the-counter {OTC} Rapid Test Kit v/s Professional Rapid Test Kit

Rapid Test Kit Market, By Technology:

Lateral Flow Assays
Solid Phase
Agglutination
Immunospot Assay

Rapid Test Kit Market, By Duration:

Less than 30 Minutes
Less than 10 Minutes
Less than 1 Hour
1 Hour - 2 Hour
Others

Rapid Test Kit Market, By Application:

Infectious Disease
Glucose Monitoring
Pregnancy & Fertility
Toxicology
Cardiology
Oncology
Others

Rapid Test Kit Market, By End User:

Hospitals & Clinics
Home Care
Diagnostic Centers
Others

Rapid Test Kit Market, By Region:

North America

United States
Canada
Mexico

Europe

France
United Kingdom
Italy
Germany
Spain

Asia Pacific

China
India
Japan
Australia
South Korea

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Rapid Test Kit Market.

Available Customizations:

Global Rapid Test Kit Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Rapid Test Kit Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Rapid Test Kit Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Type (Rapid Antigen Test v/s Rapid Antibody Test)

5.2.2. By Product Type (Over-the-counter {OTC} Rapid Test Kit v/s Professional Rapid Test Kit)

5.2.3. By Technology (Lateral Flow Assays, Solid Phase, Agglutination, Immunospot Assay)

5.2.4. By Duration (Less than 30 Minutes, Less than 10 Minutes, Less than 1 Hour, 1 Hour - 2 Hour, Others)

5.2.5. By Application (Infectious Disease, Glucose Monitoring, Pregnancy & Fertility, Toxicology, Cardiology, Oncology, Others)

5.2.6. By End User (Hospitals & Clinics, Home Care, Diagnostic Centers, Others)

5.2.7. By Region

5.2.8. By Company (2025)

5.3. Market Map

6. North America Rapid Test Kit Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Type

6.2.2. By Product Type

6.2.3. By Technology

6.2.4. By Duration

6.2.5. By Application

6.2.6. By End User

6.2.7. By Country

6.3. North America: Country Analysis

6.3.1. United States Rapid Test Kit Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Type

6.3.1.2.2. By Product Type

6.3.1.2.3. By Technology

6.3.1.2.4. By Duration

6.3.1.2.5. By Application

6.3.1.2.6. By End User

6.3.2. Canada Rapid Test Kit Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Type

6.3.2.2.2. By Product Type

6.3.2.2.3. By Technology

6.3.2.2.4. By Duration

6.3.2.2.5. By Application

6.3.2.2.6. By End User

6.3.3. Mexico Rapid Test Kit Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Type

6.3.3.2.2. By Product Type

6.3.3.2.3. By Technology

6.3.3.2.4. By Duration

6.3.3.2.5. By Application

6.3.3.2.6. By End User

7. Europe Rapid Test Kit Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Type

7.2.2. By Product Type

7.2.3. By Technology

7.2.4. By Duration

7.2.5. By Application

7.2.6. By End User

7.2.7. By Country

7.3. Europe: Country Analysis

7.3.1. Germany Rapid Test Kit Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Type

7.3.1.2.2. By Product Type

7.3.1.2.3. By Technology

7.3.1.2.4. By Duration

7.3.1.2.5. By Application

7.3.1.2.6. By End User

7.3.2. France Rapid Test Kit Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Type

7.3.2.2.2. By Product Type

7.3.2.2.3. By Technology

7.3.2.2.4. By Duration

7.3.2.2.5. By Application

7.3.2.2.6. By End User

7.3.3. United Kingdom Rapid Test Kit Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Type

7.3.3.2.2. By Product Type

7.3.3.2.3. By Technology

7.3.3.2.4. By Duration

7.3.3.2.5. By Application

7.3.3.2.6. By End User

7.3.4. Italy Rapid Test Kit Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Type

7.3.4.2.2. By Product Type

7.3.4.2.3. By Technology

7.3.4.2.4. By Duration

7.3.4.2.5. By Application

7.3.4.2.6. By End User

7.3.5. Spain Rapid Test Kit Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Type

7.3.5.2.2. By Product Type

7.3.5.2.3. By Technology

7.3.5.2.4. By Duration

7.3.5.2.5. By Application

7.3.5.2.6. By End User

8. Asia Pacific Rapid Test Kit Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type

8.2.2. By Product Type

8.2.3. By Technology

8.2.4. By Duration

8.2.5. By Application

8.2.6. By End User

8.2.7. By Country

8.3. Asia Pacific: Country Analysis

8.3.1. China Rapid Test Kit Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Type

8.3.1.2.2. By Product Type

8.3.1.2.3. By Technology

8.3.1.2.4. By Duration

8.3.1.2.5. By Application

8.3.1.2.6. By End User

8.3.2. India Rapid Test Kit Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Type

8.3.2.2.2. By Product Type

8.3.2.2.3. By Technology

8.3.2.2.4. By Duration

8.3.2.2.5. By Application

8.3.2.2.6. By End User

8.3.3. Japan Rapid Test Kit Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Type

8.3.3.2.2. By Product Type

8.3.3.2.3. By Technology

8.3.3.2.4. By Duration

8.3.3.2.5. By Application

8.3.3.2.6. By End User

8.3.4. South Korea Rapid Test Kit Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Type

8.3.4.2.2. By Product Type

8.3.4.2.3. By Technology

8.3.4.2.4. By Duration

8.3.4.2.5. By Application

8.3.4.2.6. By End User

8.3.5. Australia Rapid Test Kit Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Type

8.3.5.2.2. By Product Type

8.3.5.2.3. By Technology

8.3.5.2.4. By Duration

8.3.5.2.5. By Application

8.3.5.2.6. By End User

9. Middle East & Africa Rapid Test Kit Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Type

9.2.2. By Product Type

9.2.3. By Technology

9.2.4. By Duration

9.2.5. By Application

9.2.6. By End User

9.2.7. By Country

9.3. Middle East & Africa: Country Analysis

9.3.1. Saudi Arabia Rapid Test Kit Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Type

9.3.1.2.2. By Product Type

9.3.1.2.3. By Technology

9.3.1.2.4. By Duration

9.3.1.2.5. By Application

9.3.1.2.6. By End User

9.3.2. UAE Rapid Test Kit Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Type

9.3.2.2.2. By Product Type

9.3.2.2.3. By Technology

9.3.2.2.4. By Duration

9.3.2.2.5. By Application

9.3.2.2.6. By End User

9.3.3. South Africa Rapid Test Kit Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Type

9.3.3.2.2. By Product Type

9.3.3.2.3. By Technology

9.3.3.2.4. By Duration

9.3.3.2.5. By Application

9.3.3.2.6. By End User

10. South America Rapid Test Kit Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Type

10.2.2. By Product Type

10.2.3. By Technology

10.2.4. By Duration

10.2.5. By Application

10.2.6. By End User

10.2.7. By Country

10.3. South America: Country Analysis

10.3.1. Brazil Rapid Test Kit Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Type

10.3.1.2.2. By Product Type

10.3.1.2.3. By Technology

10.3.1.2.4. By Duration

10.3.1.2.5. By Application

10.3.1.2.6. By End User

10.3.2. Colombia Rapid Test Kit Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Type

10.3.2.2.2. By Product Type

10.3.2.2.3. By Technology

10.3.2.2.4. By Duration

10.3.2.2.5. By Application

10.3.2.2.6. By End User

10.3.3. Argentina Rapid Test Kit Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Type

10.3.3.2.2. By Product Type

10.3.3.2.3. By Technology

10.3.3.2.4. By Duration

10.3.3.2.5. By Application

10.3.3.2.6. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)

12.2. Product Launches (If Any)

12.3. Recent Developments

13. Global Rapid Test Kit Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Abbott Laboratories

15.1.1. Business Overview

15.1.2. Products & Services

15.1.3. Recent Developments

15.1.4. Key Personnel

15.1.5. SWOT Analysis

15.2. F. Hoffmann-La Roche Ltd.

15.3. Siemens Healthineers

15.4. Danaher Corporation

15.5. Becton, Dickinson and Company (BD)

15.6. bioMérieux SA

15.7. Thermo Fisher Scientific Inc.

15.8. PerkinElmer Inc.

15.9. Bio-Rad Laboratories Inc.

15.10. ACON Laboratories Inc.

16. Strategic Recommendations

17. About Us & Disclaimer

Figures and Tables

Figure 1: Global Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 2: Global Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 3: Global Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 4: Global Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 5: Global Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 6: Global Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 7: Global Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 8: Global Rapid Test Kit Market Share, By Region, By Value, 2016-2026F

Figure 9: Global Rapid Test Kit Market Share, By Company, By Value, 2020

Figure 10: Global Rapid Test Kit Market Map, By Type, Market Size (USD Billion) & Growth Rate (%), 2020

Figure 11: Global Rapid Test Kit Market Map, By Region, Market Size (USD Billion) & Growth Rate (%), 2020

Figure 12: North America Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 13: North America Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 14: North America Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 15: North America Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 16: North America Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 17: North America Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 18: North America Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 19: North America Rapid Test Kit Market Share, By Country, By Value, 2016-2026F

Figure 20: United States Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 21: Leading Causes of Death in United States in 2020 (Per 100,000 Population)

Figure 22: United States Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 23: United States Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 24: United States Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 25: United States Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 26: United States Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 27: United States Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 28: Canada Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 29: Canada Hospital Establishments, By Region, 2019 (Units)

Figure 30: Canada Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 31: Canada Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 32: Canada Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 33: Canada Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 34: Canada Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 35: Canada Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 36: Mexico Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 37: Mexico Healthcare Spending, By Value, 2015 -2019 (USD Per Capita)

Figure 38: Mexico Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 39: Mexico Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 40: Mexico Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 41: Mexico Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 42: Mexico Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 43: Mexico Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 44: Europe Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 45: Europe Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 46: Europe Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 47: Europe Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 48: Europe Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 49: Europe Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 50: Europe Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 51: Europe Rapid Test Kit Market Share, By Country, By Value, 2016-2026F

Figure 52: France Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 53: France Total Population (In Million), 2016-2020

Figure 54: France Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 55: France Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 56: France Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 57: France Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 58: France Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 59: France Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 60: Germany Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 61: Germany New Cancer Cases, By Type, 2020

Figure 62: Germany Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 63: Germany Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 64: Germany Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 65: Germany Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 66: Germany Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 67: Germany Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 68: United Kingdom Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 69: Geriatric Population Numbers and Projections in United Kingdom (Millions), 2020

Figure 70: United Kingdom Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 71: United Kingdom Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 72: United Kingdom Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 73: United Kingdom Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 74: United Kingdom Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 75: United Kingdom Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 76: Italy Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 77: New Cancer Cases in Italy (%), Males, All Ages, 2020

Figure 78: Italy Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 79: Italy Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 80: Italy Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 81: Italy Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 82: Italy Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 83: Italy Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 84: Spain Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 85: Number of New Cancer Cases in Spain, By Cancer Site, 2020

Figure 86: Spain Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 87: Spain Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 88: Spain Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 89: Spain Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 90: Spain Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 91: Spain Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 92: Asia-Pacific Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 93: Asia-Pacific Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 94: Asia-Pacific Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 95: Asia-Pacific Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 96: Asia-Pacific Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 97: Asia-Pacific Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 98: Asia-Pacific Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 99: Asia-Pacific Rapid Test Kit Market Share, By Country, By Value, 2016-2026F

Figure 100: China Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 101: New Cancer Cases in China (%), 2020

Figure 102: China Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 103: China Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 104: China Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 105: China Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 106: China Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 107: China Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 108: Japan Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 109: Japan Total Health Expenditure as a Share of GDP, 2015-2019

Figure 110: Japan Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 111: Japan Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 112: Japan Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 113: Japan Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 114: Japan Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 115: Japan Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 116: India Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 117: Growing Share of Geriatric Population (Above 60 Years) in India (2015-2019)

Figure 118: India Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 119: India Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 120: India Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 121: India Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 122: India Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 123: India Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 124: South Korea Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 125: New Cancer Cases in South Korea (%), 2019

Figure 126: South Korea Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 127: South Korea Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 128: South Korea Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 129: South Korea Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 130: South Korea Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 131: South Korea Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 132: Australia Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 133: % of Public and Private Hospitals in Australia, 2020

Figure 134: Australia Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 135: Australia Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 136: Australia Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 137: Australia Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 138: Australia Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 139: Australia Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 140: South America Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 141: South America Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 142: South America Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 143: South America Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 144: South America Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 145: South America Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 146: South America Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 147: South America Rapid Test Kit Market Share, By Country, By Value, 2016-2026F

Figure 148: Brazil Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 149: Brazil Healthcare Spending, By Value (USD Per Capita), 2015-2019

Figure 150: Brazil Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 151: Brazil Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 152: Brazil Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 153: Brazil Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 154: Brazil Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 155: Brazil Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 156: Argentina Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 157: Argentina Health Expenditure (% of GDP), 2015-2019

Figure 158: Argentina Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 159: Argentina Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 160: Argentina Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 161: Argentina Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 162: Argentina Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 163: Argentina Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 164: Colombia Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 165: Colombia Healthcare Expenditure, By Value (USD Billion), 2015-2020

Figure 166: Colombia Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 167: Colombia Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 168: Colombia Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 169: Colombia Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 170: Colombia Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 171: Colombia Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 172: Middle East & Africa Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 173: Middle East & Africa Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 174: Middle East & Africa Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 175: Middle East & Africa Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 176: Middle East & Africa Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 177: Middle East & Africa Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 178: Middle East & Africa Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 179: Middle East & Africa Rapid Test Kit Market Share, By Country, By Value, 2016-2026F

Figure 180: South Africa Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 181: South Africa New Cancer Cases, By Type, 2020

Figure 182: South Africa Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 183: South Africa Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 184: South Africa Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 185: South Africa Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 186: South Africa Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 187: South Africa Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 188: Saudi Arabia Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 189: Saudi Arabia Geriatric Population (Aged 65 & Above) As a Percent of Total Population, 2016-2020

Figure 190: Saudi Arabia Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 191: Saudi Arabia Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 192: Saudi Arabia Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 193: Saudi Arabia Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 194: Saudi Arabia Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 195: Saudi Arabia Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 196: UAE Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 197: UAE Health Expenditure (% of GDP), 2015-2019

Figure 198: UAE Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 199: UAE Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 200: UAE Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 201: UAE Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 202: UAE Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 203: UAE Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

Figure 204: Kuwait Rapid Test Kit Market Size, By Value (USD Billion), 2016-2026F

Figure 205: Number of 5-year Cancer Prevalence Cases in General Population of Kuwait as of 2020, By Type

Figure 206: Kuwait Rapid Test Kit Market Share, By Type, By Value, 2016-2026F

Figure 207: Kuwait Rapid Test Kit Market Share, By Product Type, By Value, 2016-2026F

Figure 208: Kuwait Rapid Test Kit Market Share, By Technology, By Value, 2016-2026F

Figure 209: Kuwait Rapid Test Kit Market Share, By Duration, By Value, 2016-2026F

Figure 210: Kuwait Rapid Test Kit Market Share, By Application, By Value, 2016-2026F

Figure 211: Kuwait Rapid Test Kit Market Share, By End-User, By Value, 2016-2026F

List of Tables:

Table 1: List of Approved Major Rapid Test Kit in North America, By Brand

Table 2: List of Approved Major Rapid Test Kit in Europe, By Brand

Table 3: List of Approved Major Rapid Test Kit in Asia Pacific, By Brand

Table 4: List of Approved Major Rapid Test Kit in South America, By Brand

Table 5: List of Approved Major Rapid Test Kit in Middle East & Africa, By Brand

Table 6: Number of Persons Aged 65 Years or Above by Geographic Region, 2019 and 2050

Report Description

Table of content

Figures and Tables

Frequently asked questions

What was the market size of the Global Rapid Test Kit Market in 2025?

Which is the dominating region in the Global Rapid Test Kit Market?

Which is the fastest growing segment in the Global Rapid Test Kit Market?

What is the expected growth rate of the Global Rapid Test Kit Market?